7 authorised products containing Paclitaxel, from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Abraxane 5 mg/ml powder for dispersion for infusion EU/1/07/428/001 |
Paclitaxel | Bristol-Myers Squibb Pharma EEIG | — |
| Apacross 5 mg/ml powder for dispersion for infusion PA22766/015/001 |
Paclitaxel | Seacross Pharma (Europe) Limited | Not marketed |
| Apexelsin 5 mg/ml powder for dispersion for infusion. EU/1/24/1835/001 |
Paclitaxel | Whiteoak Pharmaceutical B.V. | — |
| Naveruclif 5 mg/ml powder for dispersion for infusion EU/1/23/1778/001 |
Paclitaxel | Accord Healthcare S.L.U. | — |
| Paclitaxel 6 mg/ml concentrate for solution for infusion PA2059/050/001 |
Paclitaxel | Fresenius Kabi Deutschland GmbH | Marketed |
| Paclitaxel 6 mg/ml, Concentrate for Solution for Infusion PA2315/115/001 |
Paclitaxel | Accord Healthcare Ireland Ltd. | Marketed |
| Pazenir 5 mg/ml Powder for dispersion for infusion EU/1/18/1317/001 |
Paclitaxel | Ratiopharm GmbH | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.